KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Times Interest Earned (2018 - 2020)

Historic Times Interest Earned for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q2 2020 value amounting to -$4.19.

  • Xenon Pharmaceuticals' Times Interest Earned rose 8543.47% to -$4.19 in Q2 2020 from the same period last year, while for Mar 2021 it was -$255.37, marking a year-over-year decrease of 81842.84%. This contributed to the annual value of -$64.67 for FY2020, which is 11658.36% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Times Interest Earned of -$4.19 as of Q2 2020, which was up 8543.47% from -$24.34 recorded in Q1 2020.
  • Over the past 5 years, Xenon Pharmaceuticals' Times Interest Earned peaked at -$4.19 during Q2 2020, and registered a low of -$49.09 during Q1 2018.
  • In the last 3 years, Xenon Pharmaceuticals' Times Interest Earned had a median value of -$28.8 in 2019 and averaged -$28.46.
  • Its Times Interest Earned has fluctuated over the past 5 years, first tumbled by 1785.14% in 2019, then skyrocketed by 8543.47% in 2020.
  • Xenon Pharmaceuticals' Times Interest Earned (Quarter) stood at -$20.92 in 2018, then plummeted by 59.28% to -$33.33 in 2019, then skyrocketed by 87.41% to -$4.19 in 2020.
  • Its last three reported values are -$4.19 in Q2 2020, -$24.34 for Q1 2020, and -$33.33 during Q4 2019.